Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone Plus Chloroquine for Hyper-reactive Malarial Splenomegaly
NCT01785979Phase 3Withdrawn
- Sponsor
- Lihir Medical Centre
- Start
- Jan 2016
- Primary completion
- Feb 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisone in Hyper-reactive malarial splenomegaly syndrome (HMSS), sponsored by Lihir Medical Centre. Planned start Jan 2016; status: withdrawn.
02
Drugs
prednisone
03
Conditions
Hyper-reactive malarial splenomegaly syndrome (HMSS)
Beyond the preview
Go deeper on NCT01785979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01785979.